SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006635
Filing Date
2020-05-15
Accepted
2020-05-14 18:43:36
Documents
92
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20200331x10q.htm 10-Q 2243174
2 EX-31.1 jagx-20200331ex311361bc9.htm EX-31.1 12630
3 EX-31.2 jagx-20200331ex3123badd2.htm EX-31.2 12549
4 EX-32.1 jagx-20200331ex3214ca484.htm EX-32.1 7923
5 EX-32.2 jagx-20200331ex322429b62.htm EX-32.2 7850
  Complete submission text file 0001558370-20-006635.txt   10602352

Data Files

Seq Description Document Type Size
6 EX-101.INS jagx-20200331.xml EX-101.INS 2082156
7 EX-101.SCH jagx-20200331.xsd EX-101.SCH 102353
8 EX-101.CAL jagx-20200331_cal.xml EX-101.CAL 49667
9 EX-101.DEF jagx-20200331_def.xml EX-101.DEF 516525
10 EX-101.LAB jagx-20200331_lab.xml EX-101.LAB 758585
11 EX-101.PRE jagx-20200331_pre.xml EX-101.PRE 704235
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 20879799
SIC: 2834 Pharmaceutical Preparations